This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Biomedical International R + D Gmbh. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Araceli Diaz Perales: Innovator in Allergy Diagnosis and Treatment
Introduction
Araceli Diaz Perales is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of allergy diagnosis and treatment. With a focus on innovative methods and means, her work has the potential to improve the lives of many individuals suffering from allergies.
Latest Patents
Araceli Diaz Perales holds 2 patents related to her groundbreaking work. One of her latest patents is a method for diagnosing allergies in human or animal patients. This method involves measuring the level of species-specific lipocalin, particularly lipocalin 2, in a sample from the patient. A lowered level of this lipocalin compared to that in a non-allergic individual indicates the presence of an allergy. Additionally, her patent includes a kit for performing this diagnostic method and a quality control kit for allergen molecules or extracts used in immunotherapy. Furthermore, her work provides lipocalin proteins for the treatment or prevention of allergies, preferably complexed with siderophore-iron ligands.
Career Highlights
Araceli Diaz Perales is associated with Biomedical International R&D GmbH, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving diagnostic methods and treatment options for allergies.
Collaborations
Some of her notable coworkers include Franziska Roth-Walter and Erika Jensen-Jarolim. Their collaborative efforts contribute to the ongoing research and development in the field of allergy treatment.
Conclusion
Araceli Diaz Perales is a key figure in the innovation of allergy diagnosis and treatment. Her patents and research have the potential to significantly impact the medical field and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile